Your browser doesn't support javascript.
loading
Activation of EGFR-KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma.
Pang, Lijun; Xu, Lin; Yuan, Chunwang; Li, Xiuhui; Zhang, Xiangying; Wang, Wenjing; Guo, Xianghua; Ouyang, Yabo; Qiao, Luxin; Wang, Zhenchang; Liu, Kai.
Afiliação
  • Pang L; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Xu L; Beijing Institute of Hepatology, Beijing, China.
  • Yuan C; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
  • Li X; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Zhang X; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Wang W; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Guo X; Beijing Institute of Hepatology, Beijing, China.
  • Ouyang Y; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Qiao L; Beijing Institute of Hepatology, Beijing, China.
  • Wang Z; Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Liu K; Beijing Institute of Hepatology, Beijing, China.
Mol Carcinog ; 58(11): 2118-2126, 2019 11.
Article em En | MEDLINE | ID: mdl-31465134

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Fatores de Transcrição Kruppel-Like / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Fatores de Transcrição Kruppel-Like / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article